Metastatic Lung Adenocarcinoma Treatment Market Summary The global metastatic lung adenocarcinoma treatment market size was valued at USD 4.90 billion in 2024 and is projected to reach USD 9.29 billion by 2030, growing at a CAGR of 11.3 percent from 2025 to 2030. This growth is fueled by the rising incidence of lung cancer coupled with advancements in treatment options. As lung cancer...